$OFIX
Orthofix Medical Inc. Stock $ofix

$ofix Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024025877 Filed on March 05, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$188.6M	$200.4M	$746.6M
YoY Change	7.65%	63.97%	62.06%
Cost Of Revenue	$61.37M	$63.79M	$260.4M
YoY Change	-5.41%	92.98%	110.75%
Gross Profit	$127.2M	$136.6M	$486.3M
YoY Change	15.33%	53.21%	44.22%
Gross Profit Margin	67.46%	68.17%	65.13%
Selling, General & Admin	$131.7M	$132.3M	$530.4M
YoY Change	-7.65%	56.01%	71.77%
% of Gross Profit	103.5%	96.82%	109.07%
Research & Development	$19.49M	$18.94M	$80.23M
YoY Change	-16.37%	44.02%	63.52%
% of Gross Profit	15.32%	13.86%	16.5%
Depreciation & Amortization	$14.86M	$13.97M	$53.06M
YoY Change	17.3%	88.24%	82.86%
% of Gross Profit	11.68%	10.22%	10.91%
Operating Expenses	$151.2M	$151.2M	$610.6M
YoY Change	-8.88%	51.19%	70.64%
Operating Profit	-$29.34M	-$14.60M	-$139.1M
YoY Change	-50.87%	34.59%	948.46%
Interest Expense	-$4.558M	-$4.500M	-$8.631M
YoY Change	253.61%	1865.07%	570.11%
% of Operating Profit
Other Income/Expense, Net	-$1.274M	$766.0K	-$938.0K
YoY Change	-288.46%	-82.13%	-70.22%
Pretax Income	-$35.17M	-$22.05M	-$148.7M
YoY Change	-41.7%	215.57%	739.71%
Income Tax	$851.0K	$125.0K	$2.716M
% Of Pretax Income
Net Earnings	-$36.02M	-$22.17M	-$151.4M
YoY Change	-40.89%	213.99%	666.6%
Net Earnings / Revenue	-19.1%	-11.06%	-20.28%
Basic Earnings Per Share	-$0.95		-$4.12
Diluted Earnings Per Share	-$0.95	-$0.59	-$4.12
COMMON SHARES
Basic Shares Outstanding	37.41M	36.76M	36.73M
Diluted Shares Outstanding	37.74K		36.73M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.96M	$33.11M	$33.11M
YoY Change	-46.04%	-34.7%	-34.7%
Cash & Equivalents	$26.96M	$33.11M	$33.11M
Short-Term Investments
Other Short-Term Assets	$27.32M	$37.07M	$37.07M
YoY Change	10.05%	66.37%	66.37%
Inventory	$219.1M	$222.2M	$222.2M
Prepaid Expenses
Receivables	$125.6M	$128.1M	$128.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$399.0M	$420.4M	$420.4M
YoY Change	-2.7%	64.24%	64.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$158.1M	$159.1M	$159.1M
YoY Change	15.58%	173.16%	144.64%
Goodwill	$194.9M	$194.9M
YoY Change	-3.84%	173.33%
Intangibles	$112.8M	$117.5M
YoY Change	-7.67%	147.93%
Long-Term Investments
YoY Change
Other Assets	$41.25M	$33.39M	$33.39M
YoY Change	-9.23%	29.89%	87.39%
Total Long-Term Assets	$507.1M	$504.9M	$504.9M
YoY Change	0.0%	149.15%	149.15%
TOTAL ASSETS
Total Short-Term Assets	$399.0M	$420.4M	$420.4M
Total Long-Term Assets	$507.1M	$504.9M	$504.9M
Total Assets	$906.1M	$925.3M	$925.3M
YoY Change	-1.21%	101.76%	101.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$57.15M	$58.36M	$58.36M
YoY Change	24.57%	111.45%	111.45%
Accrued Expenses	$3.534M	$12.19M	$89.17M
YoY Change	9.04%	26.82%	101.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.125M	$1.250M	$1.958M
YoY Change	370.63%	91.72%	200.31%
Total Short-Term Liabilities	$150.6M	$165.2M	$165.2M
YoY Change	9.49%	97.58%	97.58%
LONG-TERM LIABILITIES
Long-Term Debt	$115.1M	$93.11M	$111.6M
YoY Change	155.71%	383.95%	480.27%
Other Long-Term Liabilities	$51.70M	$49.72M	$49.72M
YoY Change	0.7%	163.0%	163.0%
Total Long-Term Liabilities	$166.8M	$142.8M	$161.4M
YoY Change	73.1%	655.47%	323.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$150.6M	$165.2M	$165.2M
Total Long-Term Liabilities	$166.8M	$142.8M	$161.4M
Total Liabilities	$335.7M	$326.6M	$326.6M
YoY Change	32.71%	168.2%	168.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$186.2M	-$150.1M
YoY Change	211.9%	-12101.92%
Common Stock	$757.1M	$750.2M
YoY Change	4.46%	122.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$570.3M	$598.7M	$598.7M
YoY Change
Total Liabilities & Shareholders Equity	$906.1M	$925.3M	$925.3M
YoY Change	-1.21%	101.76%	101.76%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$36.02M	-$22.17M	-$151.4M
YoY Change	-40.89%	213.99%	666.6%
Depreciation, Depletion And Amortization	$14.86M	$13.97M	$53.06M
YoY Change	17.3%	88.24%	82.86%
Cash From Operating Activities	-$18.60M	-$6.694M	-$45.75M
YoY Change	-45.34%	-385.09%	296.54%
INVESTING ACTIVITIES
Capital Expenditures	$10.54M	$15.05M	$60.26M
YoY Change	-8.1%	106.94%	182.04%
Acquisitions
YoY Change
Other Investing Activities	$50.00K	$0.00	$500.0K
YoY Change	-90.0%	-100.0%
Cash From Investing Activities	-$10.87M	-$15.05M	-$33.13M
YoY Change	-163.61%	155.14%	35.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.127M
YoY Change			18.22%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.45M	25.28M	65.32M
YoY Change	34.22%	1587.58%	-83846.15%
NET CHANGE
Cash From Operating Activities	-18.60M	-6.694M	-45.75M
Cash From Investing Activities	-10.87M	-15.05M	-33.13M
Cash From Financing Activities	21.45M	25.28M	65.32M
Net Change In Cash	-8.293M	3.533M	-12.94M
YoY Change	1032.92%	-272.01%	-65.16%
FREE CASH FLOW
Cash From Operating Activities	-$18.60M	-$6.694M	-$45.75M
Capital Expenditures	$10.54M	$15.05M	$60.26M
Free Cash Flow	-$29.14M	-$21.75M	-$106.0M
YoY Change	-35.95%	341.47%	222.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000884624
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-19961
CY2023	dei	Entity Registrant Name EntityRegistrantName	ORTHOFIX MEDICAL INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1340767
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3451 Plano Parkway
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Lewisville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75056
CY2023	dei	City Area Code CityAreaCode	214
CY2023	dei	Local Phone Number LocalPhoneNumber	937-2000
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.10 par value
CY2023	dei	Trading Symbol TradingSymbol	OFIX
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	663400000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37406644
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33107000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50700000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	4650000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7130000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6419000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	128098000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	82857000
CY2023Q4	us-gaap	Inventory Net InventoryNet	222166000
CY2022Q4	us-gaap	Inventory Net InventoryNet	100150000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32422000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22283000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	420443000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	255990000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	159060000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58229000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	117490000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47388000
CY2023Q4	us-gaap	Goodwill Goodwill	194934000
CY2022Q4	us-gaap	Goodwill Goodwill	71317000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	33388000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25705000
CY2023Q4	us-gaap	Assets Assets	925315000
CY2022Q4	us-gaap	Assets Assets	458629000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	58357000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	27598000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1250000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	708000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	652000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	104908000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	55374000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	165223000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	83624000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	93107000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18532000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	19239000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	49723000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18906000
CY2023Q4	us-gaap	Liabilities Liabilities	326585000
CY2022Q4	us-gaap	Liabilities Liabilities	121769000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37165000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37165000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20162000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20162000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3717000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2016000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	746450000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	334969000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150144000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1251000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1293000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1376000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	598730000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	336860000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	925315000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	458629000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	746641000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	460713000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	464479000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	260368000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	123544000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	114914000
CY2023	us-gaap	Gross Profit GrossProfit	486273000
CY2022	us-gaap	Gross Profit GrossProfit	337169000
CY2021	us-gaap	Gross Profit GrossProfit	349565000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	385736000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	228810000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	221318000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	144659000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	79966000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	69353000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	80231000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49065000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49621000
CY2023	ofix	Acquisition Related Amortization And Remeasurement AcquisitionRelatedAmortizationAndRemeasurement	14757000
CY2022	ofix	Acquisition Related Amortization And Remeasurement AcquisitionRelatedAmortizationAndRemeasurement	-7404000
CY2021	ofix	Acquisition Related Amortization And Remeasurement AcquisitionRelatedAmortizationAndRemeasurement	17588000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-139110000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-13268000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-8315000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8631000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1288000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1837000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-938000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3150000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3343000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-148679000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17706000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13495000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2716000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2043000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24884000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-151395000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19749000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-38379000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.12
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.95
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.12
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.95
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36729258
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20053548
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19690593
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36729258
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20053548
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19690593
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1334000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	395000
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-942000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	1417000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-1771000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-2544000
CY2023	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	83000
CY2022	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-1376000
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-3486000
CY2021	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-234000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	83000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1376000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3252000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-151312000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21125000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41631000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	356864000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-38379000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3252000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15432000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6269000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	336934000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19749000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1376000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18443000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2608000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	336860000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-151395000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	83000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35707000
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	376745000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	730000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	598730000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-151395000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19749000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-38379000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	53063000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29019000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29599000
CY2023	ofix	Inventory Reserve Expenses InventoryReserveExpenses	27576000
CY2022	ofix	Inventory Reserve Expenses InventoryReserveExpenses	14907000
CY2021	ofix	Inventory Reserve Expenses InventoryReserveExpenses	10826000
CY2023	ofix	Amortization Of Inventory Fair Value Step Up AmortizationOfInventoryFairValueStepUp	36044000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	11756000
CY2023	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	7498000
CY2022	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	3056000
CY2021	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	3496000
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	820000
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	2095000
CY2021	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	444000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	579000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	314000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	24482000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	35707000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	18443000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	15432000
CY2023	ofix	Interest And Gain Loss On Investment Securities InterestAndGainLossOnInvestmentSecurities	-596000
CY2022	ofix	Interest And Gain Loss On Investment Securities InterestAndGainLossOnInvestmentSecurities	308000
CY2021	ofix	Interest And Gain Loss On Investment Securities InterestAndGainLossOnInvestmentSecurities	1146000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2700000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-17200000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3575000
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-423000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2027000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1064000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10411000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6735000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7049000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	58051000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33040000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10207000
CY2023	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-1760000
CY2022	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	874000
CY2021	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	2834000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8642000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2282000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4253000
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	4069000
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	627000
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1013000
CY2022	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	-4791000
CY2021	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	-9060000
CY2021	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	6595000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-27000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	1611000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	5045000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45753000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11538000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18475000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	60256000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21364000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17785000
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1794000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1796000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1807000
CY2022	ofix	Contingent Consideration Payments Related To Asset Acquisitions ContingentConsiderationPaymentsRelatedToAssetAcquisitions	1500000
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2171000
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	29419000
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	500000
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-126000
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1250000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33131000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24534000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23013000
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	174500000
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	79000000
CY2023	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	26899000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5127000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4337000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8824000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4397000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1729000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2555000
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1000000
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	8405000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	652000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2594000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	537000
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2357000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	92000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	948000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	65322000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-78000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3621000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	619000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-997000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-815000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12943000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37147000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8974000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	50700000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	87847000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	96821000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37757000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	50700000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	87847000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33107000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50700000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87847000
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	4650000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37757000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	50700000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	87847000
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Financial instruments and concentration of credit risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;"> </span></p><p style="margin-left:0.013%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Financial instruments that could subject the Company to a concentration of credit risk consist primarily of cash, cash equivalents, and accounts receivable. Generally, cash is held at large financial institutions and cash equivalents consist of highly liquid money market funds. The Company performs ongoing credit evaluations of customers, generally does not require collateral, and maintains a reserve for expected credit losses. The Company believes that a concentration of credit risk related to accounts receivable is limited because customers are geographically dispersed and end users are diversified.</span></p>
CY2023Q4	ofix	Banking Service Obligation BankingServiceObligation	4700000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	19893000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	112816000
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4674000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	117490000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	2000000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	500000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	500000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	500000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2200000
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	0.4163
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4861000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1538000
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	746600000
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	698200000
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-116400000
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-129200000
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	18200000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	28390000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	17035000
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	53510000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	19243000
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	140266000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	63872000
CY2023Q4	us-gaap	Inventory Net InventoryNet	222166000
CY2022Q4	us-gaap	Inventory Net InventoryNet	100150000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	537000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16688000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5603000
CY2023	us-gaap	Depreciation Depreciation	34200000
CY2022	us-gaap	Depreciation Depreciation	19600000
CY2021	us-gaap	Depreciation Depreciation	20200000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	347685000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	221225000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	188625000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	162996000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	159060000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58229000
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P9Y6M
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	215930000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	124849000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	98440000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	77461000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	117490000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47388000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18900000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9400000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9400000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	20948000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	19849000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	18810000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	18426000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14890000
CY2022Q4	us-gaap	Goodwill Goodwill	71317000
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	123617000
CY2023Q4	us-gaap	Goodwill Goodwill	194934000
CY2023Q3	ofix	Percentage Of Market Capitalization Decreased Due To Termination PercentageOfMarketCapitalizationDecreasedDueToTermination	0.30
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19869000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6788000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16345000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17360000
CY2023Q4	ofix	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	36214000
CY2022Q4	ofix	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	24148000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3477000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1638000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	708000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	652000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17125000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5376000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18532000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	19239000
CY2023Q4	ofix	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	39842000
CY2022Q4	ofix	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	26905000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P16Y7M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P17Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.044
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.044
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	589000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	149000
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1013000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1238000
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2049000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	857000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	890000
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	933000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	5015000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2126000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2234000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	313000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	152000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	213000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1883000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	932000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	815000
CY2023	us-gaap	Lease Cost LeaseCost	9081000
CY2022	us-gaap	Lease Cost LeaseCost	5338000
CY2021	us-gaap	Lease Cost LeaseCost	6244000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	7682000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	3805000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	4627000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	857000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	885000
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	907000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	652000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2594000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4788000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1543000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4607000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1562000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3441000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1593000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1785000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	1624000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	6766000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	19396000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	26248000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	27256000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5646000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	8016000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	20602000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	19240000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3477000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	708000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17125000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18532000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	20602000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	19240000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12189000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9611000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38826000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18531000
CY2023Q4	ofix	Accrued Distributor Commissions AccruedDistributorCommissions	22602000
CY2022Q4	ofix	Accrued Distributor Commissions AccruedDistributorCommissions	10483000
CY2023Q4	ofix	Accrued Litigation And Investigation Costs AccruedLitigationAndInvestigationCosts	12077000
CY2022Q4	ofix	Accrued Litigation And Investigation Costs AccruedLitigationAndInvestigationCosts	3891000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3477000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1638000
CY2023Q4	ofix	Non Income Taxes Payable NonIncomeTaxesPayable	7585000
CY2022Q4	ofix	Non Income Taxes Payable NonIncomeTaxesPayable	6586000
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	8152000
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	4634000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	104908000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	55374000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1250000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	93107000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	94357000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5800000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1400000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1500000
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2023	ofix	Number Of Former Executives Seeking Severance Payments NumberOfFormerExecutivesSeekingSeverancePayments	3
CY2023	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	1300000
CY2022	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	1200000
CY2021	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	-1200000
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	7600000
CY2023	ofix	Revenue From Product Sales RevenueFromProductSales	693345000
CY2022	ofix	Revenue From Product Sales RevenueFromProductSales	405437000
CY2021	ofix	Revenue From Product Sales RevenueFromProductSales	409554000
CY2023	ofix	Marketing Service Fees MarketingServiceFees	53296000
CY2022	ofix	Marketing Service Fees MarketingServiceFees	55276000
CY2021	ofix	Marketing Service Fees MarketingServiceFees	54925000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	746641000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	460713000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	464479000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	746641000
CY2023	ofix	Percent Of Reporting Segment Revenues To Revenues PercentOfReportingSegmentRevenuesToRevenues	1
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	460713000
CY2022	ofix	Percent Of Reporting Segment Revenues To Revenues PercentOfReportingSegmentRevenuesToRevenues	1
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	464479000
CY2021	ofix	Percent Of Reporting Segment Revenues To Revenues PercentOfReportingSegmentRevenuesToRevenues	1.000
CY2023	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	46285000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6419000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4944000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	137000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	820000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2095000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	381000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	450000
CY2023	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	-135000
CY2022	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	170000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	7130000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6419000
CY2023	ofix	Sales Of Receivables SalesOfReceivables	9200000
CY2022	ofix	Sales Of Receivables SalesOfReceivables	9200000
CY2021	ofix	Sales Of Receivables SalesOfReceivables	8400000
CY2023	ofix	Sales Of Receivables SalesOfReceivables	10000000
CY2022	ofix	Sales Of Receivables SalesOfReceivables	9600000
CY2021	ofix	Sales Of Receivables SalesOfReceivables	9900000
CY2023	ofix	Cost Related To Sale Of Accounts Receivable CostRelatedToSaleOfAccountsReceivable	400000
CY2022	ofix	Cost Related To Sale Of Accounts Receivable CostRelatedToSaleOfAccountsReceivable	300000
CY2021	ofix	Cost Related To Sale Of Accounts Receivable CostRelatedToSaleOfAccountsReceivable	200000
CY2020	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	13900000
CY2021Q2	ofix	Medicare Recoupment MedicareRecoupment	0.25
CY2022Q1	ofix	Medicare Recoupment MedicareRecoupment	0.50
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4791000
CY2022	ofix	Recoupment Recognized In Net Sales RecoupmentRecognizedInNetSales	-4791000
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	400000
CY2022	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	48553000
CY2021	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	61262000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8631000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1288000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1837000
CY2023	ofix	Depreciation Amortization And Impairment DepreciationAmortizationAndImpairment	53063000
CY2022	ofix	Depreciation Amortization And Impairment DepreciationAmortizationAndImpairment	29019000
CY2021	ofix	Depreciation Amortization And Impairment DepreciationAmortizationAndImpairment	41355000
CY2023	ofix	Adjusted Share Based Compensation Expense AdjustedShareBasedCompensationExpense	35707000
CY2022	ofix	Adjusted Share Based Compensation Expense AdjustedShareBasedCompensationExpense	18443000
CY2021	ofix	Adjusted Share Based Compensation Expense AdjustedShareBasedCompensationExpense	15432000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1581000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3291000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3981000
CY2023	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	36623000
CY2022	us-gaap	Payments For Merger Related Costs PaymentsForMergerRelatedCosts	12010000
CY2023	ofix	Strategic Investments StrategicInvestments	2272000
CY2022	ofix	Strategic Investments StrategicInvestments	4018000
CY2021	ofix	Strategic Investments StrategicInvestments	5700000
CY2023	ofix	Acquisition Related Fair Value Adjustments AcquisitionRelatedFairValueAdjustments	33393000
CY2022	ofix	Acquisition Related Fair Value Adjustments AcquisitionRelatedFairValueAdjustments	-15595000
CY2021	ofix	Acquisition Related Fair Value Adjustments AcquisitionRelatedFairValueAdjustments	-2014000
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	1781000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	187000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-644000
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-14453000
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-803000
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-33000
CY2023	ofix	Medical Device Regulation MedicalDeviceRegulation	9446000
CY2022	ofix	Medical Device Regulation MedicalDeviceRegulation	10261000
CY2021	ofix	Medical Device Regulation MedicalDeviceRegulation	8018000
CY2022	ofix	Business Interruption Covid19 BusinessInterruptionCovid19	2387000
CY2021	ofix	Business Interruption Covid19 BusinessInterruptionCovid19	320000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	1176000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	147000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	739000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-148679000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17706000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13495000
CY2022	ofix	Business Combination Acquired In Process Research And Development BusinessCombinationAcquiredInProcessResearchAndDevelopment	1600000
CY2021	ofix	Business Combination Acquired In Process Research And Development BusinessCombinationAcquiredInProcessResearchAndDevelopment	1500000
CY2023	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	-14757000
CY2022	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	-7404000
CY2021	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	17588000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	53063000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29019000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29599000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	746641000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	460713000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	464479000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	746641000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	460713000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	464479000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	159060000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	58229000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2700000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-17200000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3575000
CY2023	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	17408000
CY2022	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	8196000
CY2021	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	7907000
CY2023	ofix	Business Combination Acquired In Process Research And Development BusinessCombinationAcquiredInProcessResearchAndDevelopment	49000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35707000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18443000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15432000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35707000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18443000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15432000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5800000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3300000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3100000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.368
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.423
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.344
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.348
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0338
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0461
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0083
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0125
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.43
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.33
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1299000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.29
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1837000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	19.92
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1803000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	31.62
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3223000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.64
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y11M19D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3223000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	30.64
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y11M19D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1828000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	36.78
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y8M4D
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	0
CY2023Q4	ofix	Closing Stock Price ClosingStockPrice	13.48
CY2023Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	1700000
CY2022Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	1500000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-154794000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-22318000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5987000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	6115000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4612000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-7508000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-148679000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17706000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13495000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	17000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1151000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-607000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1160000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	67000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	24292000
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	1177000
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	1218000
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	23685000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2120000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	578000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1009000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-581000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	247000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	190000
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	1539000
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	825000
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	1199000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2716000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2043000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24884000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-31222000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3718000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2834000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3452000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.023
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1312000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.074
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-24000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.002
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-738000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.005
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	475000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.027
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	480000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.036
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	28322000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.19
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7638000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.431
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	27819000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2.061
CY2023	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	2333000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	-0.016
CY2022	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	1018000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	-0.057
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1219000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.008
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	750000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.042
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	537000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.04
CY2023	ofix	Unrecognized Tax Positions UnrecognizedTaxPositions	-71000
CY2022	ofix	Unrecognized Tax Positions UnrecognizedTaxPositions	599000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.034
CY2021	ofix	Unrecognized Tax Positions UnrecognizedTaxPositions	1363000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.101
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	4210000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.028
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	1441000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.081
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	1091000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.081
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	3030000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.02
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	697000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.039
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	456000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.034
CY2022	ofix	Income Tax Rate Reconciliation Related To Contingent Consideration From Business Combination IncomeTaxRateReconciliationRelatedToContingentConsiderationFromBusinessCombination	-3316000
CY2022	ofix	Effective Income Tax Rate Reconciliation Tax Related To Contingent Consideration From Business Combination EffectiveIncomeTaxRateReconciliationTaxRelatedToContingentConsiderationFromBusinessCombination	0.187
CY2021	ofix	Income Tax Rate Reconciliation Related To Contingent Consideration From Business Combination IncomeTaxRateReconciliationRelatedToContingentConsiderationFromBusinessCombination	-640000
CY2021	ofix	Effective Income Tax Rate Reconciliation Tax Related To Contingent Consideration From Business Combination EffectiveIncomeTaxRateReconciliationTaxRelatedToContingentConsiderationFromBusinessCombination	0.047
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1381000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.009
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	469000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.026
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	436000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.032
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2716000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.018
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2043000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.115
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24884000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.844
CY2023Q4	us-gaap	Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority	900000
CY2022Q4	us-gaap	Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority	-900000
CY2021Q4	us-gaap	Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority	4800000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	5807000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	33122000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	17819000
CY2023Q4	ofix	Deferred Tax Assets Deferred Revenue And Expenses DeferredTaxAssetsDeferredRevenueAndExpenses	4409000
CY2022Q4	ofix	Deferred Tax Assets Deferred Revenue And Expenses DeferredTaxAssetsDeferredRevenueAndExpenses	3642000
CY2023Q4	ofix	Deferred Tax Assets Accrued Expenses And Reserves DeferredTaxAssetsAccruedExpensesAndReserves	5382000
CY2022Q4	ofix	Deferred Tax Assets Accrued Expenses And Reserves DeferredTaxAssetsAccruedExpensesAndReserves	2756000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	14861000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	8795000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1821000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1253000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1227000
CY2023Q4	ofix	Defferred Tax Asset Net Operating Loss And Tax Credit Carryforwards DefferredTaxAssetNetOperatingLossAndTaxCreditCarryforwards	123210000
CY2022Q4	ofix	Defferred Tax Asset Net Operating Loss And Tax Credit Carryforwards DefferredTaxAssetNetOperatingLossAndTaxCreditCarryforwards	40676000
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	15174000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4353000
CY2023Q4	ofix	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	9632000
CY2022Q4	ofix	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	6440000
CY2023Q4	ofix	Deferred Tax Assets Liabilities Other Net DeferredTaxAssetsLiabilitiesOtherNet	5429000
CY2022Q4	ofix	Deferred Tax Assets Liabilities Other Net DeferredTaxAssetsLiabilitiesOtherNet	3767000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	214267000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	95308000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	200192000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83797000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	14075000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11511000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1662000
CY2023Q4	ofix	Deferred Tax Liabilities Withholding Taxes DeferredTaxLiabilitiesWithholdingTaxes	10000
CY2022Q4	ofix	Deferred Tax Liabilities Withholding Taxes DeferredTaxLiabilitiesWithholdingTaxes	10000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5737000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5516000
CY2023Q4	ofix	Deferred Tax Liabilities Right Of Use Lease Assets DeferredTaxLiabilitiesRightOfUseLeaseAssets	8755000
CY2022Q4	ofix	Deferred Tax Liabilities Right Of Use Lease Assets DeferredTaxLiabilitiesRightOfUseLeaseAssets	5771000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	16164000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	11297000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2089000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	214000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2081000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1470000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	4170000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1256000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2089000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	214000
CY2023Q4	ofix	Unremitted Earning Of Foreign Subsidiary UnremittedEarningOfForeignSubsidiary	33600000
CY2023	ofix	Minimum Percentage Of Income Tax Benefit MinimumPercentageOfIncomeTaxBenefit	0.50
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3000000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1700000
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	200000
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	100000
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-400000
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	100000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	900000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	400000
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1200000
CY2022Q4	ofix	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	1743000
CY2021Q4	ofix	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	3462000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	416000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	46000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	815000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	16000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	144000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1637000
CY2023Q4	ofix	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	2974000
CY2022Q4	ofix	Unrecognized Tax Benefits Excluding Interest And Penalties UnrecognizedTaxBenefitsExcludingInterestAndPenalties	1743000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36729000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20054000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19691000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36729000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20054000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19691000

Files In Submission

Name	View Source	Status
0000950170-24-025877-index-headers.html	Edgar Link	pending
0000950170-24-025877-index.html	Edgar Link	pending
0000950170-24-025877.txt	Edgar Link	pending
0000950170-24-025877-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img221738597_0.jpg	Edgar Link	pending
img221738597_1.jpg	Edgar Link	pending
img221738597_2.jpg	Edgar Link	pending
img221738597_3.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ofix-20231231.htm	Edgar Link	pending
ofix-20231231.xsd	Edgar Link	pending
ofix-ex10_16.htm	Edgar Link	pending
ofix-ex10_21.htm	Edgar Link	pending
ofix-ex21_1.htm	Edgar Link	pending
ofix-ex23_1.htm	Edgar Link	pending
ofix-ex31_1.htm	Edgar Link	pending
ofix-ex31_2.htm	Edgar Link	pending
ofix-ex32_1.htm	Edgar Link	pending
ofix-ex97_1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
ofix-20231231_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OFIX
Orthofix Medical Inc. Stock $ofix

2024 Q1 Form 10-K Financial Statement

#000095017024025877 Filed on March 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX Orthofix Medical Inc. Stock $ofix

2024 Q1 Form 10-K Financial Statement

#000095017024025877 Filed on March 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX
Orthofix Medical Inc. Stock $ofix